A small molecule Abl kinase inhibitor induces differentiation of Abelson virus–transformed pre-B cell lines (original) (raw)

References

1. Hardy, R.R. et al. B-cell commitment, development and selection. Immunol. Rev. 175, 23–32 (2000).
   CAS PubMed Google Scholar
2. Muljo, S.A. & Schlissel, M.S. Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development. Immunol. Rev. 175, 80–93 (2000).
   CAS PubMed Google Scholar
3. Grawunder, U. et al. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3, 601–608 (1995).
   CAS PubMed Google Scholar
4. Yancopoulos, G.D. & Alt, F.W. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40, 271–281 (1985).
   CAS PubMed Google Scholar
5. Schlissel, M.S. & Baltimore, D. Activation of immunoglobulin κ gene rearrangement correlates with induction of germline κ gene transcription. Cell 58, 1001–1007 (1989).
   CAS PubMed Google Scholar
6. Rosenberg, N., Baltimore, D. & Scher, C.D. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. USA 72, 1932–1936 (1975).
   CAS PubMed PubMed Central Google Scholar
7. Rosenberg, N. & Kincade, P.W. B-lineage differentiation in normal and transformed cells and the microenvironment that supports it. Curr. Opin. Immunol. 6, 203–211 (1994).
   CAS PubMed Google Scholar
8. Jackson, P. & Baltimore, D. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8, 449–456 (1989).
   CAS PubMed PubMed Central Google Scholar
9. Pluk, H., Dorey, K. & Superti-Furga, G. Autoinhibition of c-Abl. Cell 108, 247–259 (2002).
   CAS PubMed Google Scholar
10. Alt, F., Rosenberg, N., Lewis, S., Thomas, E. & Baltimore, D. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell 27, 381–390 (1981).
    CAS PubMed Google Scholar
11. Bendall, H.H., Sikes, M.L. & Oltz, E.M. Transcription factor NF-κB regulates Igλ light chain gene rearrangement. J. Immunol. 167, 264–269 (2001).
    CAS PubMed Google Scholar
12. Schlissel, M.S., Corcoran, L.M. & Baltimore, D. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173, 711–720 (1991).
    CAS PubMed Google Scholar
13. Klug, C.A. et al. The v-abl tyrosine kinase negatively regulates NF-κB/Rel factors and blocks κ gene transcription in pre-B lymphocytes. Genes Dev. 8, 678–687 (1994).
    CAS PubMed Google Scholar
14. Chen, Y.Y., Wang, L.C., Huang, M.S. & Rosenberg, N. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8, 688–697 (1994).
    CAS PubMed Google Scholar
15. Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M. & Peng, A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 7, 2520–2532 (1993).
    CAS PubMed Google Scholar
16. Stanhope-Baker, P., Hudson, K.M., Shaffer, A.L., Constantinescu, A. & Schlissel, M.S. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85, 887–897 (1996).
    CAS PubMed Google Scholar
17. Hoffmann, R., Seidl, T., Neeb, M., Rolink, A. & Melchers, F. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. 12, 98–111 (2002).
    CAS PubMed PubMed Central Google Scholar
18. Chen, J., Ma, A., Young, F. & Alt, F.W. IL-2 receptor α chain expression during early B lymphocyte differentiation. Int. Immunol. 6, 1265–1268 (1994).
    CAS PubMed Google Scholar
19. Rolink, A., Grawunder, U., Winkler, T.H., Karasuyama, H. & Melchers, F. IL-2 receptor α chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6, 1257–1264 (1994).
    CAS PubMed Google Scholar
20. Zou, X., Lin, Y., Rudchenko, S. & Calame, K. Positive and negative regulation of c-Myc transcription. Curr. Top. Microbiol. Immunol. 224, 57–66 (1997).
    CAS PubMed Google Scholar
21. Morrow, M.A., Lee, G., Gillis, S., Yancopoulos, G.D. & Alt, F.W. Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes. Genes Dev. 6, 61–70 (1992).
    CAS PubMed Google Scholar
22. Eisenbeis, C.F., Singh, H. & Storb, U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9, 1377–1387 (1995).
    CAS PubMed Google Scholar
23. Shaffer, A.L., Peng, A. & Schlissel, M.S. In vivo occupancy of the κ light chain enhancers in primary pro- and pre-B cells: a model for κ locus activation. Immunity 6, 131–143 (1997).
    CAS PubMed Google Scholar
24. Sheehy, A.M. & Schlissel, M.S. Overexpression of RelA causes G1 arrest and apoptosis in a pro-B cell line. J. Biol. Chem. 274, 8708–8716 (1999).
    CAS PubMed Google Scholar
25. Paddison, P.J. & Hannon, G.J. RNA interference: the new somatic cell genetics? Cancer Cell 2, 17–23 (2002).
    CAS PubMed Google Scholar
26. Grandori, C., Mac, J., Siebelt, F., Ayer, D.E. & Eisenman, R.N. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15, 4344–4357 (1996).
    CAS PubMed PubMed Central Google Scholar
27. Corcoran, A.E., Riddell, A., Krooshoop, D. & Venkitaraman, A.R. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391, 904–907 (1998).
    CAS PubMed Google Scholar
28. Marshall, A.J., Fleming, H.E., Wu, G.E. & Paige, C.J. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J. Immunol. 161, 6038–6045 (1998).
    CAS PubMed Google Scholar
29. Rolink, A., Grawunder, U., Haasner, D., Strasser, A. & Melchers, F. Immature surface Ig+ B cells can continue to rearrange κ and λ L chain gene loci. J. Exp. Med. 178, 1263–1270 (1993).
    CAS PubMed Google Scholar
30. Banerjee, A. & Rothman, P. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling. J. Immunol. 161, 4611–4617 (1998).
    CAS PubMed Google Scholar
31. Perkins, E.J. et al. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev. 16, 159–164 (2002).
    CAS PubMed PubMed Central Google Scholar
32. Brown, L. & McCarthy, N. DNA repair. A sense-abl response? Nature 387, 450–451 (1997).
    CAS PubMed Google Scholar
33. Jiang, D., Lenardo, M.J. & Zuniga-Pflucker, C. p53 prevents maturation to the CD4+CD8+ stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J. Exp. Med. 183, 1923–1928 (1996).
    CAS PubMed Google Scholar
34. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153–1163 (1991).
    CAS PubMed Google Scholar
35. Schwartzberg, P.L. et al. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165–1175 (1991).
    CAS PubMed Google Scholar
36. Hardin, J.D. et al. Bone marrow B lymphocyte development in c-abl-deficient mice. Cell. Immunol. 165, 44–54 (1995).
    CAS PubMed Google Scholar
37. Kruh, G.D. et al. A novel human gene closely related to the abl proto-oncogene. Science 234, 1545–1548 (1986).
    CAS PubMed Google Scholar
38. Koleske, A.J. et al. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259–1272 (1998).
    CAS PubMed Google Scholar
39. Druker, B.J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031–1037 (2001).
    CAS PubMed Google Scholar
40. Rao, S., Matsumura, A., Yoon, J. & Simon, M.C. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1. J. Biol. Chem. 274, 11115–11124 (1999).
    CAS PubMed Google Scholar
41. Su, G.H. et al. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 16, 7118–7129 (1997).
    CAS PubMed PubMed Central Google Scholar
42. Dahl, R., Ramirez-Bergeron, D.L., Rao, S. & Simon, M.C. Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. EMBO J. 21, 2220–2230 (2002).
    CAS PubMed PubMed Central Google Scholar
43. Scott, E.W., Simon, M.C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573–1577 (1994).
    CAS PubMed Google Scholar
44. Garrett-Sinha, L.A. et al. PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity 10, 399–408 (1999).
    CAS PubMed Google Scholar
45. Matsuyama, T. et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23, 2127–2136 (1995).
    CAS PubMed PubMed Central Google Scholar
46. Pongubala, J.M. et al. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol. Cell Biol. 12, 368–378 (1992).
    CAS PubMed PubMed Central Google Scholar
47. Eisenbeis, C.F., Singh, H. & Storb, U. PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin λ 2-4 enhancer. Mol. Cell Biol. 13, 6452–6461 (1993).
    CAS PubMed PubMed Central Google Scholar
48. Brass, A.L., Zhu, A.Q. & Singh, H. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J. 18, 977–991 (1999).
    CAS PubMed PubMed Central Google Scholar
49. Mittrucker, H.W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540–543 (1997).
    CAS PubMed Google Scholar
50. Xu, Y., Davidson, L., Alt, F.W. & Baltimore, D. Deletion of the Igκ light chain intronic enhancer/matrix attachment region impairs but does not abolish VκJκ rearrangement. Immunity 4, 377–385 (1996).
    CAS PubMed Google Scholar
51. Gorman, J.R. et al. The Igκ 3′ enhancer influences the ratio of Igκ versus Igλ B lymphocytes. Immunity 5, 241–252 (1996).
    CAS PubMed Google Scholar
52. Lewis, S., Rosenberg, N., Alt, F. & Baltimore, D. Continuing κ-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell 30, 807–816 (1982).
    CAS PubMed Google Scholar
53. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 (1992).
    CAS PubMed Google Scholar
54. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863–14868 (1998).
    CAS PubMed PubMed Central Google Scholar
55. Grogan, J.L. et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205–215 (2001).
    CAS PubMed Google Scholar
56. Han, S. et al. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 278, 301–305 (1997).
    CAS PubMed Google Scholar
57. DeKoter, R.P., Lee, H.J. & Singh, H. PU.1 Regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16, 297–309 (2002).
    CAS PubMed Google Scholar

Download references